Dr Lalchandani Labs Limited has postponed its Board meeting, originally set to approve the audited financial results.

This delay stems from an ongoing internal review of crucial financial and operational data, which management deems essential to complete before presenting the statements.

The company has now announced a board meeting on Wednesday, June 03, 2026, to consider and approve the financial results for the half year and year ended March 31, 2026, ensuring accuracy for stakeholders.